Collagenase Clostridium histolyticum in Dupuytren’s contracture: a guide to its use in the EU-Reference-Cited by-同舟云学术

Collagenase Clostridium histolyticum in Dupuytren’s contracture: a guide to its use in the EU

Published:2016-02-29 Issue:4 Volume:32 Page:131-137
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

McKeage Kate,Lyseng-Williamson Katherine Ann

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40267-016-0291-8.pdf

Reference26 articles.

1. Azzopardi E, Boyce DE. Clostridium histolyticum collagenase in the treatment of Dupuytren’s contracture. Br J Hosp Med. 2012;73(8):432–6.

2. Schulze SM, Tursi JP. Postapproval clinical experience in the treatment of Dupuytren’s contracture with collagenase Clostridium histolyticum (CCH): the first 1000 days. Hand. 2014;9:447–58.

3. Mafi R, Hindocha S, Khan W. Recent surgical and medical advances in the treatment of Dupuytren’s disease: a systematic review of the literature. Open Orthop J. 2012;6(Suppl 1):77–82.

4. Needle or open fasciotomy for Dupuytren’s contracture: a review of the comparative efficacy, safety, and cost-effectiveness—an update. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013.

5. Rodrigues JN, Becker GW, Ball C, et al. Surgery for Dupuytren’s contractures of the fingers. Cochrane Database Syst Rev. 2015;12:CD010143.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collagenase Clostridium histolyticum in Peyronie’s disease: a guide to its use in the EU;Drugs & Therapy Perspectives;2016-06-29